Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (6)

2014

  1. Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders

    Epilepsia, Vol. 55, Núm. 6, pp. 791-802

2013

  1. Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid?

    British Journal of Clinical Pharmacology, Vol. 75, Núm. 2, pp. 323-333

2012

  1. Cannabinoids: Novel medicines for the treatment of Huntington's disease

    Recent Patents on CNS Drug Discovery, Vol. 7, Núm. 1, pp. 41-48

2010

  1. The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB2 and adenosine receptors

    Neurobiology of Disease, Vol. 37, Núm. 2, pp. 434-440

2005

  1. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis

    Neurobiology of Disease, Vol. 20, Núm. 2, pp. 207-217

2001

  1. Changes in cannabinoid CB1 receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis

    Synapse, Vol. 41, Núm. 3, pp. 195-202